Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

The integrated approach is designed to adapt to the evolving needs of new therapeutic modalities, delivering both speed and performance.

Microplastics turned up in every human bile sample tested and pushed duct cells toward mitochondrial dysfunction and senescence, with melatonin showing protective effects.

A new metabolic mechanism describes how tumors disable “gatekeeper” cells to prevent immune response to cancer.

Directly transferring healthy mitochondria or cytoplasmic components into target cells is particularly relevant for regenerative medicine.